Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,855,600 | 2,745,500 | 1,355,300 | 6,193,700 | 4,076,900 |
| Depreciation Amortization | 1,101,900 | 719,600 | 350,300 | 1,323,900 | 956,400 |
| Income taxes - deferred | -709,800 | -413,800 | -119,100 | -134,500 | 66,200 |
| Accounts receivable | N/A | N/A | N/A | -1,350,200 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 1,271,300 | N/A |
| Other Working Capital | -548,100 | 438,000 | -102,800 | -747,400 | -232,200 |
| Other Operating Activity | 1,404,600 | -16,400 | 213,700 | -57,200 | -182,900 |
| Operating Cash Flow | $5,104,200 | $3,472,900 | $1,697,400 | $6,499,600 | $4,684,400 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,700 | -5,300 | -15,400 | 118,300 | 107,400 |
| PPE Investments | -1,018,400 | -681,600 | -300,300 | -1,387,900 | -933,200 |
| Net Acquisitions | -747,400 | -747,400 | -747,400 | -849,300 | -849,300 |
| Purchase Of Investment | -710,100 | -503,100 | -291,500 | -358,700 | -223,700 |
| Sale Of Investment | 537,200 | 461,900 | 284,800 | 757,100 | 574,100 |
| Other Investing Activity | -463,300 | -291,300 | -213,700 | -538,400 | -260,100 |
| Investing Cash Flow | $-2,383,300 | $-1,766,800 | $-1,283,500 | $-2,258,900 | $-1,584,800 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,500 | 196,300 | -3,700 | -1,494,200 | -914,300 |
| Debt Issued | 2,410,800 | N/A | N/A | 2,062,300 | 2,062,300 |
| Debt Repayment | -1,905,300 | N/A | N/A | -276,500 | -276,300 |
| Common Stock Repurchased | -500,000 | -500,000 | N/A | -500,000 | -500,000 |
| Dividend Paid | -2,313,500 | -1,543,100 | -774,800 | -2,687,100 | -2,017,100 |
| Other Financing Activity | -295,300 | -294,800 | -279,900 | -241,600 | -200,200 |
| Financing Cash Flow | $-2,604,800 | $-2,141,600 | $-1,058,400 | $-3,137,100 | $-1,845,600 |
| Exchange Rate Effect | 15,000 | -1,600 | -10,200 | 216,000 | 3,800 |
| Beginning Cash Position | 3,657,100 | 3,657,100 | 3,657,100 | 2,337,500 | 2,337,500 |
| End Cash Position | 3,788,200 | 3,220,000 | 3,002,400 | 3,657,100 | 3,595,300 |
| Net Cash Flow | $131,100 | $-437,100 | $-654,700 | $1,319,600 | $1,257,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,104,200 | 3,472,900 | 1,697,400 | 6,499,600 | 4,684,400 |
| Capital Expenditure | -1,018,400 | -681,600 | -300,300 | -1,387,900 | -933,200 |
| Free Cash Flow | 4,085,800 | 2,791,300 | 1,397,100 | 5,111,700 | 3,751,200 |